|
Class 2 Device Recall Dimension Enzymatic Creatinine Flex reagent cartridge |
|
Date Initiated by Firm |
September 29, 2008 |
Date Posted |
December 13, 2008 |
Recall Status1 |
Terminated 3 on March 27, 2009 |
Recall Number |
Z-0485-2009 |
Recall Event ID |
50075 |
510(K)Number |
K073055
|
Product Classification |
Creatinine enzymatic method - Product Code JFY
|
Product |
Dimension Enzymatic Creatinine Flex reagent cartridge, DF270.
The ECRE method is an in vitro diagnostic test for the quantitative measurement of creatinine in human serum, plasma, and urine on the clinical chemistry system. Creatinine measurements are used in the diagnosis and treatment of renal diseases, in monitoring renal dialysis, and as a calculation basis for other urine analytes.
|
Code Information |
Lot numbers: CB9107, DB9093, DB9100, EB9077, EC9077, FC9062, GA9043, GD9069, and GD9087. |
Recalling Firm/ Manufacturer |
Dade Behring, Inc. 500 GBC Drive, Mailstop 514 PO BOX 6101 Newark DE 19714-6101
|
For Additional Information Contact |
Elaine Kindell 302-631-6311
|
Manufacturer Reason for Recall |
Reagent may exhibit unflagged inaccurate patient sample results.
|
FDA Determined Cause 2 |
Component design/selection |
Action |
The recalling firm telephoned all customers on 9/29/08 to inform them of the problem. Customers were issued a letter dated 9/29/08 (and a response form) with instructions. Customers were instructed to complete the response form and fax (302-631-7242) it to Siemens Healthcare Diagnostics. For questions or additional information, contact the Siemens Technical Solutions Center at 800-441-9250. |
Quantity in Commerce |
12,773 cartons |
Distribution |
Nationwide Distribution. |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database |
510(K)s with Product Code = JFY and Original Applicant = DADE BEHRING, INC.
|
|
|
|